Target Blood Pressure for Diabetic Patients

Risk-Based Blood Pressure Targets

For diabetic patients with high cardiovascular risk, the American College of Cardiology recommends a blood pressure target of <130/80 mmHg, which may reduce the risk of stroke, as seen in the ACCORD BP trial 1, 2, 3, 4
For diabetic patients with lower cardiovascular risk, a blood pressure target of <140/90 mmHg is recommended, as strong evidence supports that treatment to this threshold reduces cardiovascular events and microvascular complications 1, 2

The ACCORD BP trial found that intensive blood pressure control did not reduce total major atherosclerotic cardiovascular events, but did reduce stroke risk, with a significant reduction in stroke observed 4, 2
Meta-analyses show that antihypertensive treatment is beneficial when mean baseline blood pressure is ≥140/90 mmHg or mean attained intensive blood pressure is ≥130/80 mmHg, with benefits seen in reducing stroke, retinopathy, and albuminuria 3
The 2022 American Diabetes Association standards of care support a risk-stratified approach to blood pressure management, with individualized targets based on cardiovascular risk 3, 4

Intensive blood pressure control may increase risks of hypotension, syncope, falls, acute kidney injury, and electrolyte abnormalities, particularly in elderly patients or those with chronic kidney disease 3, 4
For pregnant patients with diabetes and preexisting hypertension, a blood pressure target of 110–135/85 mmHg is recommended to reduce risk of maternal hypertension and minimize impaired fetal growth 2

Blood pressure should be measured at every routine clinical visit, with elevated readings confirmed using multiple readings, and all hypertensive patients with diabetes should monitor their blood pressure at home 1
Lifestyle interventions, including weight loss, DASH-style eating pattern, moderation of alcohol intake, and increased physical activity, are recommended for patients with blood pressure >120/80 mmHg 3
ACE inhibitors or ARBs are preferred first-line agents for pharmacological therapy, particularly in patients with albuminuria or renal insufficiency, while thiazide diuretics are effective in African-American patients 6, 7